GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (STU:3KY) » Definitions » Market Cap

Hansoh Pharmaceutical Group Co (STU:3KY) Market Cap : €12,847 Mil (As of May. 21, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Hansoh Pharmaceutical Group Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Hansoh Pharmaceutical Group Co's share price for the quarter that ended in Dec. 2023 was €1.71. Hansoh Pharmaceutical Group Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 5,924 Mil. Therefore, Hansoh Pharmaceutical Group Co's market cap for the quarter that ended in Dec. 2023 was €10,130 Mil.

Hansoh Pharmaceutical Group Co's quarterly market cap declined from Dec. 2022 (€10,360 Mil) to Jun. 2023 (€8,536 Mil) but then increased from Jun. 2023 (€8,536 Mil) to Dec. 2023 (€10,130 Mil).

Hansoh Pharmaceutical Group Co's annual market cap declined from Dec. 2021 (€12,318 Mil) to Dec. 2022 (€10,360 Mil) and declined from Dec. 2022 (€10,360 Mil) to Dec. 2023 (€10,130 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Hansoh Pharmaceutical Group Co's Enterprise Value for Today is €10,185 Mil.


Hansoh Pharmaceutical Group Co Market Cap Historical Data

The historical data trend for Hansoh Pharmaceutical Group Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansoh Pharmaceutical Group Co Market Cap Chart

Hansoh Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial 16,323.88 22,610.54 12,318.49 10,359.91 10,129.60

Hansoh Pharmaceutical Group Co Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,318.49 10,956.35 10,359.91 8,536.06 10,129.60

Competitive Comparison of Hansoh Pharmaceutical Group Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Hansoh Pharmaceutical Group Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hansoh Pharmaceutical Group Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hansoh Pharmaceutical Group Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Hansoh Pharmaceutical Group Co's Market Cap falls into.



Hansoh Pharmaceutical Group Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Hansoh Pharmaceutical Group Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€1.71*5923.74
=€10,130

Hansoh Pharmaceutical Group Co's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=€1.71*5923.74
=€10,130

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hansoh Pharmaceutical Group Co  (STU:3KY) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Hansoh Pharmaceutical Group Co Market Cap Related Terms

Thank you for viewing the detailed overview of Hansoh Pharmaceutical Group Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Hansoh Pharmaceutical Group Co (STU:3KY) Business Description

Traded in Other Exchanges
Address
287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210
Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.

Hansoh Pharmaceutical Group Co (STU:3KY) Headlines

No Headlines